National Healthcare Quality and Disparities Report
Latest available findings on quality of and access to health care
Data
- Data Infographics
- Data Visualizations
- Data Tools
- Data Innovations
- All-Payer Claims Database
- Healthcare Cost and Utilization Project (HCUP)
- Medical Expenditure Panel Survey (MEPS)
- AHRQ Quality Indicator Tools for Data Analytics
- State Snapshots
- United States Health Information Knowledgebase (USHIK)
- Data Sources Available from AHRQ
Search All Research Studies
AHRQ Research Studies
Sign up: AHRQ Research Studies Email updates
Research Studies is a compilation of published research articles funded by AHRQ or authored by AHRQ researchers.
Results
1 to 2 of 2 Research Studies DisplayedSmith LB, Desai NR, Dowd B
Patient and provider-level factors associated with changes in utilization of treatments in response to evidence on ineffectiveness or harm.
High-quality health care not only includes timely access to effective new therapies but timely abandonment of therapies when they are found to be ineffective or unsafe. Little is known about changes in use of medications after they are shown to be ineffective or unsafe. In this study, the investigators examined changes in use of two medications: fenofibrate, which was found to be ineffective when used with statins among patients with Type 2 diabetes (ACCORD lipid trial); and dronedarone, which was found to be unsafe in patients with permanent atrial fibrillation (PALLAS trial).
AHRQ-funded; HS025164.
Citation: Smith LB, Desai NR, Dowd B .
Patient and provider-level factors associated with changes in utilization of treatments in response to evidence on ineffectiveness or harm.
Int J Health Econ Manag 2020 Sep;20(3):299-317. doi: 10.1007/s10754-020-09282-2..
Keywords: Healthcare Utilization, Medication, Medication: Safety, Patient Safety, Quality of Care
Fischer SH, Tjia J, Reed G
Factors associated with ordering laboratory monitoring of high-risk medications.
This study examined physician and patient factors associated with ordering recommended laboratory monitoring tests for high-risk medications. Test ordering was associated with higher provider prescribing volume for study drugs and specialist status. Patients with higher comorbidity burden and older patients were more likely to have appropriate tests ordered.
AHRQ-funded; HS017203; HS017817; HS017906
Citation: Fischer SH, Tjia J, Reed G .
Factors associated with ordering laboratory monitoring of high-risk medications.
J Gen Intern Med. 2014 Dec;29(12):1589-98. doi: 10.1007/s11606-014-2907-9..
Keywords: Medication, Patient Safety, Healthcare Utilization